Latest Dydrogesterone Stories
Elsevier announced today the publication of two further important position statements from the European Menopause and Andropause Society (EMAS) in the journal Maturitas (http://www.maturitas.org/ ) on common management problems in the post-reproductive health of women.
Hormone replacement therapy (HRT) skin patches containing low doses of oestrogen carry less risk of stroke than oral therapy and may represent a safer alternative to tablets, suggests a study published on bmj.com today.
By Panay, Nicholas Pritsch, Maria; Alt, Jeannette Abstract Secondary amenorrhea in women with normal estrogen levels increases the risk of endometrial carcinoma.
By Pelinescu-Onciul, Dimitrie Abstract The objective of the study was to evaluate the efficacy of progestogenic therapy for the prevention of spontaneous abortions in patients with subchorionic hemorrhage.
By Trivedi, Prakash Selvaraj, Kamala; Mahapatra, P Das; Srivastava, Saroj; Malik, Sonia Abstract An open, prospective, multicenter study was designed to assess the efficacy and safety of dydrogesterone in the post- laparoscopic treatment of endometriosis in Indian patients.
By Patki, Ameet Pawar, Vijay C Abstract The aim of the present study was to evaluate dydrogesterone for luteal-phase support in assisted reproductive technologies (ART) and to compare it with micronized vaginal progesterone.
By Seeger, Harald Mueck, Alfred O Abstract Estrogens exert beneficial effects on the vascular system, while progestogens generally have a negative impact (e.g. vasoconstrictor effects on the arterial system).
By Amy Norton NEW YORK (Reuters Health) - Women who use over-the-counter progesterone creams could be exposed to hormone levels comparable to those used in a form of hormone replacement therapy, a small study suggests.
- totally perplexed and mixed up.